Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes

Peter J Dyck, Jenny L. Davies, Vicki M. Clark, William J Litchy, P. James B Dyck, Christopher Jon Klein, Robert A. Rizza, John M. Pach, Ronald Klein, Timothy S. Larson, L. Joseph Melton, Peter C. O'Brien

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

OBJECTIVE - The degree to which chronic glycemic exposure (CGE) (fasting plasma glucose [FPG], HbA1c [A1C], duration of diabetes, age at onset of diabetes, or combinations of these) is associated with or predicts the severity of microvessel complications is unsettled. Specifically, we test whether combinations of components correlate and predict complications better than individual components. RESEARCH DESIGN AND METHODS - Correlations and predictions of CGE and complications were assessed in the Rochester Diabetic Neuropathy Study, a population-based, cross-sectional, and longitudinal epidemiologic survey of 504 patients with diabetes followed for up to 20 years. RESULTS - In multivariate analysis, A1C and duration of diabetes (and to a lesser degree age at onset of diabetes but not FPG) were the main significant CGE risk covariates for complications. A derived glycemic exposure index (GEi) correlated with and predicted complications better than did individual components. Composite or staged measures of polyneuropathy provided higher correlations and better predictions than did dichotomous measures of whether polyneuropathy was present or not. Generally, the mean GEi was significantly higher with increasing stages of severity of complications. CONCLUSIONS - A combination of A1C, duration of diabetes, and age at onset of diabetes (a mathematical index, GEi) correlates significantly with complications and predicts later complications better than single components of CGE. Serial measures of A1C improved the correlations and predictions. For polyneuropathy, continuous or staged measurements performed better than dichotomous judgments. Even with intensive assessment of CGE and complications over long times, only about one-third of the variability of the severity of complications is explained, emphasizing the role of other putative risk covariates.

Original languageEnglish (US)
Pages (from-to)2282-2288
Number of pages7
JournalDiabetes Care
Volume29
Issue number10
DOIs
StatePublished - Oct 2006

Fingerprint

Glycemic Index
Polyneuropathies
Diabetes Complications
Age of Onset
Fasting
Glucose
Diabetic Neuropathies
Microvessels
Longitudinal Studies
Research Design
Multivariate Analysis
Population

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. / Dyck, Peter J; Davies, Jenny L.; Clark, Vicki M.; Litchy, William J; Dyck, P. James B; Klein, Christopher Jon; Rizza, Robert A.; Pach, John M.; Klein, Ronald; Larson, Timothy S.; Melton, L. Joseph; O'Brien, Peter C.

In: Diabetes Care, Vol. 29, No. 10, 10.2006, p. 2282-2288.

Research output: Contribution to journalArticle

Dyck, PJ, Davies, JL, Clark, VM, Litchy, WJ, Dyck, PJB, Klein, CJ, Rizza, RA, Pach, JM, Klein, R, Larson, TS, Melton, LJ & O'Brien, PC 2006, 'Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes', Diabetes Care, vol. 29, no. 10, pp. 2282-2288. https://doi.org/10.2337/dc06-0525
Dyck, Peter J ; Davies, Jenny L. ; Clark, Vicki M. ; Litchy, William J ; Dyck, P. James B ; Klein, Christopher Jon ; Rizza, Robert A. ; Pach, John M. ; Klein, Ronald ; Larson, Timothy S. ; Melton, L. Joseph ; O'Brien, Peter C. / Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. In: Diabetes Care. 2006 ; Vol. 29, No. 10. pp. 2282-2288.
@article{0ef59e15e1da406ea703c7c760c5e5a8,
title = "Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes",
abstract = "OBJECTIVE - The degree to which chronic glycemic exposure (CGE) (fasting plasma glucose [FPG], HbA1c [A1C], duration of diabetes, age at onset of diabetes, or combinations of these) is associated with or predicts the severity of microvessel complications is unsettled. Specifically, we test whether combinations of components correlate and predict complications better than individual components. RESEARCH DESIGN AND METHODS - Correlations and predictions of CGE and complications were assessed in the Rochester Diabetic Neuropathy Study, a population-based, cross-sectional, and longitudinal epidemiologic survey of 504 patients with diabetes followed for up to 20 years. RESULTS - In multivariate analysis, A1C and duration of diabetes (and to a lesser degree age at onset of diabetes but not FPG) were the main significant CGE risk covariates for complications. A derived glycemic exposure index (GEi) correlated with and predicted complications better than did individual components. Composite or staged measures of polyneuropathy provided higher correlations and better predictions than did dichotomous measures of whether polyneuropathy was present or not. Generally, the mean GEi was significantly higher with increasing stages of severity of complications. CONCLUSIONS - A combination of A1C, duration of diabetes, and age at onset of diabetes (a mathematical index, GEi) correlates significantly with complications and predicts later complications better than single components of CGE. Serial measures of A1C improved the correlations and predictions. For polyneuropathy, continuous or staged measurements performed better than dichotomous judgments. Even with intensive assessment of CGE and complications over long times, only about one-third of the variability of the severity of complications is explained, emphasizing the role of other putative risk covariates.",
author = "Dyck, {Peter J} and Davies, {Jenny L.} and Clark, {Vicki M.} and Litchy, {William J} and Dyck, {P. James B} and Klein, {Christopher Jon} and Rizza, {Robert A.} and Pach, {John M.} and Ronald Klein and Larson, {Timothy S.} and Melton, {L. Joseph} and O'Brien, {Peter C.}",
year = "2006",
month = "10",
doi = "10.2337/dc06-0525",
language = "English (US)",
volume = "29",
pages = "2282--2288",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "10",

}

TY - JOUR

T1 - Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes

AU - Dyck, Peter J

AU - Davies, Jenny L.

AU - Clark, Vicki M.

AU - Litchy, William J

AU - Dyck, P. James B

AU - Klein, Christopher Jon

AU - Rizza, Robert A.

AU - Pach, John M.

AU - Klein, Ronald

AU - Larson, Timothy S.

AU - Melton, L. Joseph

AU - O'Brien, Peter C.

PY - 2006/10

Y1 - 2006/10

N2 - OBJECTIVE - The degree to which chronic glycemic exposure (CGE) (fasting plasma glucose [FPG], HbA1c [A1C], duration of diabetes, age at onset of diabetes, or combinations of these) is associated with or predicts the severity of microvessel complications is unsettled. Specifically, we test whether combinations of components correlate and predict complications better than individual components. RESEARCH DESIGN AND METHODS - Correlations and predictions of CGE and complications were assessed in the Rochester Diabetic Neuropathy Study, a population-based, cross-sectional, and longitudinal epidemiologic survey of 504 patients with diabetes followed for up to 20 years. RESULTS - In multivariate analysis, A1C and duration of diabetes (and to a lesser degree age at onset of diabetes but not FPG) were the main significant CGE risk covariates for complications. A derived glycemic exposure index (GEi) correlated with and predicted complications better than did individual components. Composite or staged measures of polyneuropathy provided higher correlations and better predictions than did dichotomous measures of whether polyneuropathy was present or not. Generally, the mean GEi was significantly higher with increasing stages of severity of complications. CONCLUSIONS - A combination of A1C, duration of diabetes, and age at onset of diabetes (a mathematical index, GEi) correlates significantly with complications and predicts later complications better than single components of CGE. Serial measures of A1C improved the correlations and predictions. For polyneuropathy, continuous or staged measurements performed better than dichotomous judgments. Even with intensive assessment of CGE and complications over long times, only about one-third of the variability of the severity of complications is explained, emphasizing the role of other putative risk covariates.

AB - OBJECTIVE - The degree to which chronic glycemic exposure (CGE) (fasting plasma glucose [FPG], HbA1c [A1C], duration of diabetes, age at onset of diabetes, or combinations of these) is associated with or predicts the severity of microvessel complications is unsettled. Specifically, we test whether combinations of components correlate and predict complications better than individual components. RESEARCH DESIGN AND METHODS - Correlations and predictions of CGE and complications were assessed in the Rochester Diabetic Neuropathy Study, a population-based, cross-sectional, and longitudinal epidemiologic survey of 504 patients with diabetes followed for up to 20 years. RESULTS - In multivariate analysis, A1C and duration of diabetes (and to a lesser degree age at onset of diabetes but not FPG) were the main significant CGE risk covariates for complications. A derived glycemic exposure index (GEi) correlated with and predicted complications better than did individual components. Composite or staged measures of polyneuropathy provided higher correlations and better predictions than did dichotomous measures of whether polyneuropathy was present or not. Generally, the mean GEi was significantly higher with increasing stages of severity of complications. CONCLUSIONS - A combination of A1C, duration of diabetes, and age at onset of diabetes (a mathematical index, GEi) correlates significantly with complications and predicts later complications better than single components of CGE. Serial measures of A1C improved the correlations and predictions. For polyneuropathy, continuous or staged measurements performed better than dichotomous judgments. Even with intensive assessment of CGE and complications over long times, only about one-third of the variability of the severity of complications is explained, emphasizing the role of other putative risk covariates.

UR - http://www.scopus.com/inward/record.url?scp=33845439073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845439073&partnerID=8YFLogxK

U2 - 10.2337/dc06-0525

DO - 10.2337/dc06-0525

M3 - Article

C2 - 17003307

AN - SCOPUS:33845439073

VL - 29

SP - 2282

EP - 2288

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 10

ER -